4//SEC Filing
Pine Michael Craig 4
Accession 0001562180-22-000469
CIK 0001314102other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 2:14 PM ET
Size
5.7 KB
Accession
0001562180-22-000469
Insider Transaction Report
Form 4
Pine Michael Craig
Chief Corp Dev.&Strat. Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-10+100,000→ 100,000 totalExercise: $12.62Exp: 2032-01-10→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001904458
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 2:14 PM ET
- Size
- 5.7 KB